Alternatives
Alternatives to Matzim LA 300 mg extended-release tablet
2 other presentations of Diltiazem 300 mg extended-release tablet
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Diltiazem), strength (300 mg) and dosage form (extended-release tablet) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Matzim LA 300 mg extended-release tabletThis pageOral | Actavis Pharma | US FDA | 90 tablets, 30 tablets | Store at 20° to 25°C (68° to 77°F). Avoid excessive humidity and temperatures above 30°C (86°F). | On request | — | Available on request |
| Diltiazem 300 mg extended-release tabletOral | — | US FDA | 30 tablets, 90 tablets | Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Avoid excessive humidity and temperatures above 30°C (86°F). | On request | — | Available on request |
| Cardizem LA 300 mg extended-release tabletOral | Bausch Health | US FDA | 30 tablets, 90 tablets | Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Avoid excessive humidity and temperatures above 30°C (86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Matzim LA 300 mg extended-release tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.